» Articles » PMID: 6336952

Acyclovir (Zovirax) in Herpetic Disciform Keratitis

Overview
Journal Br J Ophthalmol
Specialty Ophthalmology
Date 1983 Feb 1
PMID 6336952
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Forty patients with disciform keratitis were randomly assigned to double-blind treatment with 3% acyclovir and 0.01% betamethasone drops or acyclovir and matching placebo. All patients who received the combination healed in a median time of 21 days, while 11 of 19 patients who received acyclovir alone were withdrawn because their condition remained static or worsened (p less than 0.001). The combination therapy produced a faster rate of healing (p = 0.004); other clinical parameters also improved more favourably in the combination treatment group. Three patients had mild transient punctate keratopathy, but no serious adverse effects were seen despite treatment for a median duration of 28 days in the acyclovir group and 38 days in the combined therapy group. A combination of acyclovir and dilute steroid drops is effective in the management of disciform keratitis.

Citing Articles

Steroids in the Management of Infectious Keratitis.

Keenan J Cornea. 2023; 42(11):1333-1339.

PMID: 38112645 PMC: 10730951. DOI: 10.1097/ICO.0000000000003340.


Adoption of Innovation in Herpes Simplex Virus Keratitis.

Chodosh J, Ung L Cornea. 2020; 39 Suppl 1:S7-S18.

PMID: 32732703 PMC: 7664964. DOI: 10.1097/ICO.0000000000002425.


Local delivery of corticosteroids in clinical ophthalmology: A review.

Fung A, Tran T, Lim L, Samarawickrama C, Arnold J, Gillies M Clin Exp Ophthalmol. 2019; 48(3):366-401.

PMID: 31860766 PMC: 7187156. DOI: 10.1111/ceo.13702.


Corneal lymphangiogenesis in herpetic stromal keratitis.

Park P, Chang M, Garg N, Zhu J, Chang J, Shukla D Surv Ophthalmol. 2014; 60(1):60-71.

PMID: 25444520 PMC: 4262646. DOI: 10.1016/j.survophthal.2014.06.001.


Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.

Richards D, Carmine A, Brogden R, Heel R, Speight T, Avery G Drugs. 1983; 26(5):378-438.

PMID: 6315332 DOI: 10.2165/00003495-198326050-00002.


References
1.
Kaufman H . Editorial: Herpetic stromal disease. Am J Ophthalmol. 1975; 80(6):1092-4. DOI: 10.1016/0002-9394(75)90343-8. View

2.
ELION G, Furman P, Fyfe J, de Miranda P, Beauchamp L, Schaeffer H . Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci U S A. 1977; 74(12):5716-20. PMC: 431864. DOI: 10.1073/pnas.74.12.5716. View

3.
Schaeffer H, Beauchamp L, de Miranda P, ELION G, Bauer D, Collins P . 9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group. Nature. 1978; 272(5654):583-5. DOI: 10.1038/272583a0. View

4.
Jones B, Coster D, Fison P, Thompson G, Cobo L, Falcon M . Efficacy of acycloguanosine (Wellcome 248U) against herpes-simplex corneal ulcers. Lancet. 1979; 1(8110):243-4. DOI: 10.1016/s0140-6736(79)90769-4. View

5.
Coster D, Wilhelmus K, Michaud R, Jones B . A comparison of acyclovir and idoxuridine as treatment for ulcerative herpetic keratitis. Br J Ophthalmol. 1980; 64(10):763-5. PMC: 1043812. DOI: 10.1136/bjo.64.10.763. View